Search Results - "Frassi, Micol"

A real-world economic analysis of biologic therapies for psoriatic arthritis in Italy: results of the CHRONOS observational longitudinal study.

Authors: Zagni, Emanuela Frassi, Micol Mariano, Giuseppa Pagano et al.

Source: BMC Health Services Research. 12/19/2022, Vol. 22 Issue 1, p1-17. 17p.

The Risk of Developing Ocular Involvement Among Behçet's Disease Patients Presenting with Mucocutaneous Involvement at Disease Onset: Data from the International AIDA Network Behçet's Disease Registry.

Authors: Vitale, Antonio Caggiano, Valeria Sbalchiero, Jessica et al.

Source: Ophthalmology & Therapy. Jan2026, Vol. 15 Issue 1, p223-237. 15p.

Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosus.

Authors: Bortoluzzi, Alessandra Marangoni, Antonio Silvagni, Ettore et al.

Source: Scientific Reports. 10/13/2025, Vol. 15 Issue 1, p1-10. 10p.

A retrospective study of patients with adult-onset Still's disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need?

Authors: Dall'Ara, Francesca Frassi, Micol Tincani, Angela et al.

Source: Clinical Rheumatology. Aug2016, Vol. 35 Issue 8, p2117-2123. 7p.

The use of non-TNF targeted biologics in Behçet's disease: real‐life data from the International AIDA Network Behçet's Disease Registry.

Authors: Sevik, Gizem Lopalco, Giuseppe Iannone, Florenzo et al.

Source: Rheumatology. May2026, Vol. 65 Issue 5, p1-9. 9p.

Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders.

Authors: Sota, Jurgen Guerriero, Silvana Lopalco, Giuseppe et al.

Source: Ocular Immunology & Inflammation. Jan2025, Vol. 33 Issue 1, p48-55. 8p.

Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology.

Authors: Sebastiani, Gian Domenico Spinelli, Francesca Romana Bartoloni, Elena et al.

Source: Lupus. Jul2021, Vol. 30 Issue 8, p1233-1243. 11p. 5 Charts.

Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial.

Authors: Ruscitti, Piero Masedu, Francesco Alvaro, Saverio et al.

Source: PLoS Medicine. 9/12/2019, Vol. 16 Issue 9, p1-22. 22p. 1 Diagram, 5 Charts, 2 Graphs.

Pregnancy and autoimmunity: Maternal treatment and maternal disease influence on pregnancy outcome

Authors: Tincani, Angela Rebaioli, Chiara Biasini Frassi, Micol et al.

Source: Autoimmunity Reviews. Sep2005, Vol. 4 Issue 7, p423-428. 6p.

Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: observational study from the International AIDA Registry.

Authors: Sota, Jurgen Rigante, Donato Cimaz, Rolando et al.

Source: Rheumatology. Dec2021, Vol. 60 Issue 12, p5705-5712. 8p.

Follow-Up of Infants Exposed to Hydroxychloroquine Given to Mothers during Pregnancy and Lactation.

Authors: Motta, Mario Tincani, Angela Faden, David et al.

Source: Journal of Perinatology. Feb2005, Vol. 25 Issue 2, p86-89. 4p.

Human leukocyte antigens class II in CIDP spectrum neuropathies.

Authors: Cotti Piccinelli, Stefano Carella, Graziella Frassi, Micol et al.

Source: Journal of the Neurological Sciences. Dec2019, Vol. 407, pN.PAG-N.PAG. 1p.

Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study.

Authors: Sota, Jurgen Vitale, Antonio Insalaco, Antonella et al.

Source: Clinical Rheumatology. Aug2018, Vol. 37 Issue 8, p2233-2240. 8p. 3 Color Photographs, 1 Chart, 1 Graph.

Thymic and Bone Marrow Output in Patients with Common Variable Immunodeficiency.

Authors: Serana, Federico Airò, Paolo Chiarini, Marco et al.

Source: Journal of Clinical Immunology. Jul2011, Vol. 31 Issue 4, p540-549. 10p. 1 Chart, 3 Graphs.

Risk of intestinal involvement in mucocutaneous-onset Behçet's disease: data from the AIDA network registry.

Authors: Vitale A Caggiano V Sbalchiero J et al.

Source: Frontiers in immunology [Front Immunol] 2026 May 13; Vol. 17, pp. 1778171. Date of Electronic Publication: 2026 May 13 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Application of machine learning techniques to explore the occurrence of macrophage activation syndrome in Still's disease: results from the GIRRCS AOSD Study Group and the AIDA Network Still's Disease Registry.

Authors: Ruscitti P Masedu F Vitale A et al.

Source: Frontiers in immunology [Front Immunol] 2026 Apr 14; Vol. 17, pp. 1811317. Date of Electronic Publication: 2026 Apr 14 (Print Publication: 2026).

Publication Type: Journal Article; Multicenter Study; Observational Study

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA Network.

Authors: Caggiano V Sbalchiero J Frassi M et al.

Source: Frontiers in immunology [Front Immunol] 2026 Mar 13; Vol. 17, pp. 1753412. Date of Electronic Publication: 2026 Mar 13 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries.

Authors: Caggiano V Sbalchiero J Frassi M et al.

Source: Frontiers in medicine [Front Med (Lausanne)] 2026 Jan 12; Vol. 12, pp. 1659758. Date of Electronic Publication: 2026 Jan 12 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE

Correction to: IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry.

Authors: Calabrese L Cartocci A Vitale A et al.

Source: Clinical and experimental rheumatology [Clin Exp Rheumatol] 2026 May; Vol. 44 (5), pp. 1056. Date of Electronic Publication: 2026 May 07.

Publication Type: Published Erratum; Journal Article

Journal Info: Publisher: Clinical And Experimental Rheumatology S.A.S Country of Publication: Italy NLM ID: 8308521 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0392-856X (Print) Linking ISSN: 0392856X NLM ISO Abbreviation: Clin Exp Rheumatol Subsets: MEDLINE; In Process

VEXAS syndrome and cancer: Insights about a possible "Tip of the Iceberg". Ambidirectional data from the international AIDA network registries.

Authors: Gavioli F Caggiano V Sbalchiero J et al.

Source: Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2026 Apr; Vol. 77, pp. 152932. Date of Electronic Publication: 2026 Jan 22.

Publication Type: Journal Article

Journal Info: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 1306053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-866X (Electronic) Linking ISSN: 00490172 NLM ISO Abbreviation: Semin Arthritis Rheum Subsets: MEDLINE